Onsdag 13 November | 02:07:19 Europe / Stockholm

Svenska | English

Photocure

Kalender

	Tid*
2024-11-13	08:00	Kvartalsrapport 2024-Q3
2024-08-07	-	Kvartalsrapport 2024-Q2
2024-05-24	-	X-dag ordinarie utdelning PHO 0.00 NOK
2024-05-23	-	Årsstämma
2024-05-15	-	Kvartalsrapport 2024-Q1
2024-02-21	-	Bokslutskommuniké 2023
2023-11-08	-	Kvartalsrapport 2023-Q3
2023-08-09	-	Kvartalsrapport 2023-Q2
2023-05-10	-	Kvartalsrapport 2023-Q1
2023-05-04	-	X-dag ordinarie utdelning PHO 0.00 NOK
2023-05-03	-	Årsstämma
2023-02-24	-	Bokslutskommuniké 2022
2023-02-23	-	Bokslutskommuniké 2022
2022-11-02	-	Kvartalsrapport 2022-Q3
2022-08-10	-	Kvartalsrapport 2022-Q2
2022-05-11	-	Kvartalsrapport 2022-Q1
2022-04-29	-	X-dag ordinarie utdelning PHO 0.00 NOK
2022-04-28	-	Årsstämma
2022-02-23	-	Bokslutskommuniké 2021
2021-11-17	-	Kvartalsrapport 2021-Q3
2021-08-11	-	Kvartalsrapport 2021-Q2
2021-07-28	-	Extra Bolagsstämma 2021
2021-05-21	-	X-dag ordinarie utdelning PHO 0.00 NOK
2021-05-20	-	Årsstämma
2021-05-19	-	Kvartalsrapport 2021-Q1
2021-03-03	-	Bokslutskommuniké 2020
2020-11-10	-	Kvartalsrapport 2020-Q3
2020-08-18	-	Kvartalsrapport 2020-Q2
2020-06-11	-	X-dag ordinarie utdelning PHO 0.00 NOK
2020-06-10	-	Årsstämma
2020-05-07	-	Kvartalsrapport 2020-Q1
2020-02-27	-	Bokslutskommuniké 2019
2019-11-07	-	Kvartalsrapport 2019-Q3
2019-08-07	-	Kvartalsrapport 2019-Q2
2019-06-19	-	Extra Bolagsstämma 2019
2019-05-14	-	Kvartalsrapport 2019-Q1
2019-05-10	-	X-dag ordinarie utdelning PHO 0.00 NOK
2019-05-09	-	Årsstämma
2019-02-27	-	Bokslutskommuniké 2018
2018-11-08	-	Kvartalsrapport 2018-Q3
2018-08-08	-	Kvartalsrapport 2018-Q2
2018-05-23	-	Kvartalsrapport 2018-Q1
2018-05-11	-	X-dag ordinarie utdelning PHO 0.00 NOK
2018-05-09	-	Årsstämma
2018-02-27	-	Bokslutskommuniké 2017
2017-11-08	-	Kvartalsrapport 2017-Q3
2017-08-23	-	Kvartalsrapport 2017-Q2
2017-05-23	-	Kvartalsrapport 2017-Q1
2017-04-28	-	X-dag ordinarie utdelning PHO 0.00 NOK
2017-04-27	-	Årsstämma
2017-02-15	-	Bokslutskommuniké 2016
2016-11-15	-	Kvartalsrapport 2016-Q3
2016-08-23	-	Kvartalsrapport 2016-Q2
2016-05-10	-	Kvartalsrapport 2016-Q1
2016-04-29	-	X-dag ordinarie utdelning PHO 0.00 NOK
2016-04-28	-	Årsstämma
2016-02-11	-	Bokslutskommuniké 2015
2015-10-29	-	Kvartalsrapport 2015-Q3
2015-08-13	-	Kvartalsrapport 2015-Q2
2015-05-06	-	Kvartalsrapport 2015-Q1
2015-05-02	-	X-dag ordinarie utdelning PHO 0.00 NOK
2015-04-30	-	Årsstämma
2015-02-12	-	Bokslutskommuniké 2014
2014-11-06	-	Kvartalsrapport 2014-Q3
2014-08-26	-	Kvartalsrapport 2014-Q2
2014-05-28	-	X-dag ordinarie utdelning PHO 0.00 NOK
2014-05-27	-	Årsstämma
2014-05-07	-	Kvartalsrapport 2014-Q1
2014-02-27	-	Bokslutskommuniké 2013
2013-10-23	-	Kvartalsrapport 2013-Q3
2013-08-22	-	Kvartalsrapport 2013-Q2
2013-05-23	-	X-dag ordinarie utdelning
2013-05-22	-	Årsstämma
2013-04-25	-	Kvartalsrapport 2013-Q1
2013-02-28	-	Bokslutskommuniké 2012
2012-10-26	-	Kvartalsrapport 2012-Q3
2012-08-24	-	Kvartalsrapport 2012-Q2
2012-05-10	-	Årsstämma
2012-04-26	-	Kvartalsrapport 2012-Q1
2012-02-16	-	Bokslutskommuniké 2011
2011-10-26	-	Kvartalsrapport 2011-Q3
2011-08-18	-	Kvartalsrapport 2011-Q2
2011-04-27	-	Kvartalsrapport 2011-Q1
2011-04-27	-	Årsstämma
2011-02-17	-	Bokslutskommuniké 2010
2010-10-27	-	Kvartalsrapport 2010-Q3
2010-08-19	-	Kvartalsrapport 2010-Q2
2010-04-28	-	Kvartalsrapport 2010-Q1
2010-02-19	-	Bokslutskommuniké 2009
2009-11-26	-	X-dag bonusutdelning

Beskrivning

Land	Norge
Lista	OB Match
Sektor	Hälsovård
Industri	Medicinteknik

Photocure är verksamma inom medicinteknik. Bolaget specialiserar sig inom lösningar för fotodynamisk teknik. Idag används lösningarna för behandling av sjukdomar som föranlett cancer i urinblåsan och HPV. Huvudmarknaderna återfinns inom dermatologi och onkologi, där produkterna används av sjukhus och forskningsinstitut på global nivå. Bolaget grundades 1993 och har huvudkontor i Oslo, Norge.

Filter

År

Typ

Språk

Rensa

2024-11-06 16:48:55 Photocure ASA: Invitation to presentation of third quarter 2024 financial results 53,90 NOK | +1,70% | 4,27 MNOK

2024-11-06 16:48:51 Photocure ASA: Invitation to presentation of third quarter 2024 financial results 53,90 NOK | +1,70% | 4,27 MNOK

2024-11-05 10:34:57 PHO: Photocure Partner Asieris announces Marketing Approval by the National Medical Products Administration for Hexvix in China 53,20 NOK | +3,91% | 11,2 MNOK

2024-11-05 10:34:51 Photocure Partner Asieris announces Marketing Approval by the National Medical Products Administration for Hexvix in China 53,20 NOK | +3,91% | 11,2 MNOK

2024-09-30 08:00:10 PHO: Photocure Partner Asieris Unveils Cevira (APL-1702) Phase III Subgroup Analysis by Age Groups at the 2024 CSCO Annual Meeting 55,20 NOK | +5,14% | 10,2 MNOK

2024-09-30 08:00:00 Photocure Partner Asieris Unveils Cevira (APL-1702) Phase III Subgroup Analysis by Age Groups at the 2024 CSCO Annual Meeting 55,20 NOK | +5,14% | 10,2 MNOK

2024-09-27 08:00:17 PHO: Photocure establishes Named Patient Program to provide access to Hexvix in South Africa 52,50 NOK | -1,32% | 3,99 MNOK

2024-09-27 08:00:00 Photocure establishes Named Patient Program to provide access to Hexvix in South Africa 52,50 NOK | -1,32% | 3,99 MNOK

2024-09-17 12:10:07 Cevira (APL-1702): Photocure Partner Asieris Unveils Efficacy Data of Non-Surgical Treatment of Cervical HSIL at the 2024 PDT&PD Conference 53,20 NOK | -0,37% | 10,7 MNOK

2024-09-17 12:09:52 Cevira (APL-1702): Photocure Partner Asieris Unveils Efficacy Data of Non-Surgical Treatment of Cervical HSIL at the 2024 PDT&PD Conference 53,20 NOK | -0,37% | 10,7 MNOK

2024-09-16 11:17:17 PHO: Notification of major shareholding 53,40 NOK | 0,00% | 3,26 MNOK

2024-08-07 08:00:12 Photocure ASA: Results for the second quarter of 2024 50,50 NOK | +0,80% | 4,39 MNOK

2024-08-07 08:00:00 Photocure ASA: Results for the second quarter of 2024 50,50 NOK | +0,80% | 4,39 MNOK

2024-07-31 12:00:32 Photocure ASA: Invitation to presentation of second quarter and first half year 2024 financial results 55,30 NOK | -0,36% | 1,48 MNOK

2024-07-31 12:00:21 Photocure ASA: Invitation to presentation of second quarter and first half year 2024 financial results 55,30 NOK | -0,36% | 1,48 MNOK

2024-07-15 17:52:48 PHO: Photocure and Richard Wolf Enter into Agreement to Develop a High-Definition Flexible Blue Light Cystoscope for Global Commercialization 53,70 NOK | -8,36% | 31,8 MNOK

2024-07-15 17:52:32 Photocure and Richard Wolf Enter into Agreement to Develop a High-Definition Flexible Blue Light Cystoscope for Global Commercialization 53,70 NOK | -8,36% | 31,8 MNOK

2024-06-04 08:00:12 PHO: Photocure Announces Mobile BLC Tower Initiative to Expand Access to Cysview in the U.S. 67,30 NOK | +1,20% | 10,7 MNOK

2024-06-04 08:00:00 Photocure Announces Mobile BLC Tower Initiative to Expand Access to Cysview in the U.S. 67,30 NOK | +1,20% | 10,7 MNOK

2024-05-23 19:33:17 Photocure ASA - Annual general meeting held 59,60 NOK | +2,94% | 5,86 MNOK

2024-05-23 19:33:05 Photocure ASA - Annual general meeting held 59,60 NOK | +2,94% | 5,86 MNOK

2024-05-15 08:00:17 Photocure ASA: Results for the first quarter of 2024 60,20 NOK | -4,14% | 9,37 MNOK

2024-05-15 08:00:00 Photocure ASA: Results for the first quarter of 2024 60,20 NOK | -4,14% | 9,37 MNOK

2024-05-12 10:24:06 PHO: Photocure Partner Asieris announces New Drug Application acceptance for regulatory review of Cevira in China

2024-05-12 10:23:51 Photocure Partner Asieris announces New Drug Application acceptance for regulatory review of Cevira in China

2024-05-08 22:36:13 Photocure ASA: Invitation to presentation of first quarter 2024 financial results

2024-05-08 22:36:04 Photocure ASA: Invitation to presentation of first quarter 2024 financial results

2024-05-07 08:00:25 Bladder Cancer: Long-Term Benefits of Blue Light Cystoscopy and Enhanced Detection with HD Technology Unveiled at AUA 2024 56,90 NOK | +0,71% | 1,92 MNOK

2024-05-07 08:00:00 Photocure: Bladder Cancer: Long-Term Benefits of Blue Light Cystoscopy and Enhanced Detection with HD Technology Unveiled at AUA 2024 56,90 NOK | +0,71% | 1,92 MNOK

2024-04-30 13:49:10 Photocure ASA - Notice of the Annual General Meeting 23 May 2024 55,30 NOK | -2,47% | 2,57 MNOK

2024-04-30 13:48:58 Photocure ASA - Notice of the Annual General Meeting 23 May 2024 55,30 NOK | -2,47% | 2,57 MNOK

2024-04-30 11:52:08 Photocure ASA: Annual Report 2023 55,30 NOK | -2,47% | 2,57 MNOK

2024-04-30 11:52:00 Photocure ASA: Annual Report 2023 55,30 NOK | -2,47% | 2,57 MNOK

2024-04-30 07:30:15 Bladder Cancer: pivotal trial results and new real-world evidence, to be presented at AUA 2024, demonstrate improved diagnostic and clinical outcomes with blue light cystoscopy 55,30 NOK | -2,47% | 2,57 MNOK

2024-04-30 07:30:00 Photocure: Bladder Cancer: pivotal trial results and new real-world evidence, to be presented at AUA 2024, demonstrate improved diagnostic and clinical outcomes with blue light cystoscopy 55,30 NOK | -2,47% | 2,57 MNOK

2024-04-25 21:53:29 Photocure ASA - Share option grant 55,40 NOK | +1,84% | 7,09 MNOK

2024-04-25 21:53:25 Photocure ASA - Share option grant 55,40 NOK | +1,84% | 7,09 MNOK

2024-04-08 12:33:13 PHO: European Association of Urology (EAU) 2024 congress features new data on modern technology use in bladder cancer care 58,20 NOK | +1,04% | 3,15 MNOK

2024-04-08 12:32:57 Photocure: European Association of Urology (EAU) 2024 congress features new data on modern technology use in bladder cancer care 58,20 NOK | +1,04% | 3,15 MNOK

2024-04-05 07:30:07 PHO: Photocure to Participate in the 23[rd] Annual Needham Virtual Healthcare Conference 57,60 NOK | +1,23% | 4,33 MNOK

2024-04-05 07:30:00 Photocure to Participate in the 23[rd] Annual Needham Virtual Healthcare Conference 57,60 NOK | +1,23% | 4,33 MNOK

2024-03-28 13:14:08 New Publication: Racial Difference in Detection Rate of Bladder Cancer Using Blue Light Cystoscopy 53,60 NOK | -2,55% | 6,40 MNOK

2024-03-28 13:13:55 Photocure: New Publication: Racial Difference in Detection Rate of Bladder Cancer Using Blue Light Cystoscopy 53,60 NOK | -2,55% | 6,40 MNOK

2024-03-18 10:05:58 PHO: Photocure Partner Asieris announces positive international Phase III clinical trial results for Cevira and data presentations at the 2024 EUROGIN Congress and SGO Annual Meeting 62,00 NOK | +3,68% | 30,3 MNOK

2024-03-18 10:05:49 Photocure Partner Asieris announces positive international Phase III clinical trial results for Cevira and data presentations at the 2024 EUROGIN Congress and SGO Annual Meeting 62,00 NOK | +3,68% | 30,3 MNOK

2024-02-23 08:35:07 PHO: Photocure Partner Asieris to Unveil Results of the international multicenter Phase III clinical Study for Cevira, a non-surgical treatment for cervical HSIL, at the 2024 SGO 54,60 NOK | -1,80% | 14,3 MNOK

2024-02-23 08:34:52 Photocure Partner Asieris to Unveil Results of the international multicenter Phase III clinical Study for Cevira, a non-surgical treatment for cervical HSIL, at the 2024 SGO 54,60 NOK | -1,80% | 14,3 MNOK

2024-02-22 08:37:29 PHO: Photocure Partner Asieris to present First-ever Results of the international multicenter Phase III clinical Study for Cevira, a non-surgical treatment for cervical HSIL, at the 2024 EUROGIN 55,60 NOK | -0,71% | 18,6 MNOK

Visa fler

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Photocure

Kalender

Beskrivning

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden